NYSE:BCR - New York Stock Exchange, Inc. - US0673831097
331.24
-1.95 (-0.59%)
The current stock price of BCR is 331.24 null. In the past month the price decreased by -1.65%. In the past year, price increased by 47.44%.
C. R. Bard, Inc., together with its subsidiaries, designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters; biopsy devices; and a range of minimally invasive devices for the treatment of peripheral vascular and end-stage renal diseases. It also provides urology products, including Foley catheters to reduce the rate of urinary tract infections; fecal incontinence products; brachytherapy devices and radioactive seeds for the treatment of prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems etc.
BARD C R INC
730 CENTRAL AVE
MURRAY HILL NJ 07974
CEO: Timothy M. Ring
Phone: 908-277-8000
The current stock price of BCR is 331.24 null. The price decreased by -0.59% in the last trading session.
The exchange symbol of BARD C R INC is BCR and it is listed on the New York Stock Exchange, Inc. exchange.
BCR stock is listed on the New York Stock Exchange, Inc. exchange.
BARD C R INC (BCR) has a market capitalization of 24.14B null. This makes BCR a Large Cap stock.
BARD C R INC (BCR) has a support level at 331.23 and a resistance level at 332.05. Check the full technical report for a detailed analysis of BCR support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BARD C R INC (BCR) has a dividend yield of 0.24%. The yearly dividend amount is currently 1.04. Check the full fundamental report for a detailed analysis of BCR dividend history, reliability and sustainability.
The PE ratio for BARD C R INC (BCR) is 43.42. This is based on the reported non-GAAP earnings per share of 7.63 and the current share price of 331.24 null. Check the full fundamental report for a full analysis of the valuation metrics for BCR.
ChartMill assigns a technical rating of 7 / 10 to BCR. When comparing the yearly performance of all stocks, BCR is one of the better performing stocks in the market, outperforming 85.44% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to BCR. BCR has an excellent profitability rating, but there are some minor concerns on its financial health.
Over the last trailing twelve months BCR reported a non-GAAP Earnings per Share(EPS) of 7.6288. The EPS increased by 12.33% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 14.73% | ||
ROA | 10.25% | ||
ROE | 28.3% | ||
Debt/Equity | 0.57 |